| LLY |
Eli Lilly and Company |
0 |
5.39% |
|
|
|
|
|
N/A |
0.00% |
40.95% |
42.16% |
|---|
| PFE |
Pfizer Inc. |
0 |
5.28% |
|
|
|
|
|
N/A |
0.00% |
26.97% |
13.94% |
|---|
| ABBV |
AbbVie Inc. |
0 |
5.22% |
|
|
|
|
|
N/A |
0.00% |
27.65% |
25.61% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
5.12% |
|
|
|
|
|
N/A |
0.00% |
36.29% |
48.54% |
|---|
| BMY |
Bristol-Myers Squibb Company |
0 |
5.09% |
|
|
|
|
|
N/A |
0.00% |
31.00% |
27.64% |
|---|
| ABT |
Abbott Laboratories |
0 |
5.05% |
|
|
|
|
|
N/A |
0.00% |
23.75% |
25.37% |
|---|
| JNJ |
Johnson & Johnson |
0 |
4.83% |
|
|
|
|
|
N/A |
0.00% |
19.10% |
20.87% |
|---|
| AMGN |
Amgen Inc. |
0 |
4.64% |
|
|
|
|
|
N/A |
0.00% |
34.50% |
47.20% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
0 |
3.22% |
|
|
|
|
|
N/A |
0.00% |
72.63% |
20.17% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.95% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
0 |
2.92% |
|
|
|
|
|
N/A |
0.00% |
43.71% |
27.41% |
|---|
| LQDA |
Liquidia Corporation |
0 |
2.91% |
|
|
|
|
|
N/A |
0.00% |
66.08% |
40.08% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
0 |
2.84% |
|
|
|
|
|
N/A |
0.00% |
31.17% |
52.18% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
0 |
2.79% |
|
|
|
|
|
N/A |
0.00% |
54.28% |
20.68% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
2.77% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
32.21% |
|---|
| BIIB |
Biogen Inc. |
0 |
2.70% |
|
|
|
|
|
N/A |
0.00% |
37.26% |
39.84% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
77.53% |
-0.77% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
0 |
2.68% |
|
|
|
|
|
N/A |
0.00% |
55.89% |
16.76% |
|---|
| VTRS |
Viatris Inc. |
0 |
2.65% |
|
|
|
|
|
N/A |
0.00% |
30.87% |
29.47% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
2.64% |
|
|
|
|
|
N/A |
0.00% |
67.35% |
47.41% |
|---|
| OCUL |
Ocular Therapeutix, Inc. |
0 |
2.63% |
|
|
|
|
|
N/A |
0.00% |
132.65% |
59.45% |
|---|
| ANIP |
ANI Pharmaceuticals, Inc. |
0 |
2.63% |
|
|
|
|
|
N/A |
0.00% |
50.20% |
37.95% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
28.23% |
22.40% |
|---|
| INVA |
Innoviva, Inc. |
0 |
2.59% |
|
|
|
|
|
N/A |
0.00% |
52.77% |
25.74% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
0 |
2.56% |
|
|
|
|
|
N/A |
0.00% |
51.23% |
29.31% |
|---|
| PRGO |
Perrigo Company plc |
0 |
2.55% |
|
|
|
|
|
N/A |
0.00% |
43.05% |
20.57% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
0 |
2.52% |
|
|
|
|
|
N/A |
0.00% |
65.42% |
36.69% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
55.34% |
84.59% |
|---|
| GERN |
Geron Corporation |
0 |
2.31% |
|
|
|
|
|
N/A |
0.00% |
92.88% |
14.58% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|